Statement Re: Appointment to NHS GP IT Futures

Written by Customer Service on . Posted in Public Companies.

DXS INTERNATIONAL PLCAppointment to NHS GP IT FuturesDXS International plc (“DXS”), the healthcare information and digital clinical decision support systems provider, is pleased to announce that it has been awarded a place on the new NHS GPIT Futures framework. This framework, beginning on the 1st January 2020, will enable GP Practices to purchase  DXS products and services funded centrally by the NHS rather than from their own practice funds.This GPIT Futures award follows an evaluation of a tender to The Health & Social Care Information Centre (known as NHS Digital).GPIT Futures replaces the current GPSoC2 framework, where DXS is currently an accredited Supplier of Clinical Decision Support to UK Primary Care, and where our Core Solution, DXS Point of Care is currently centrally funded by the NHS. All approved products and services will be placed on the NHS Digital Online Buying Catalogue that will make it easy for GP Practices to purchase DXS products and services.All Suppliers that have achieved this award will be required to meet separate approval for their products and services.  DXS has already made substantial progress towards satisfying these requirements.The DXS Board is extremely positive about this development that adds three new DXS products, into which we have been making significant investment, on to the centrally funded catalogue.David Immelman, DXS CEO commented:“I am delighted that the DXS’ team’s hard work, dedication and expertise have been rewarded by this award. This is an exciting time for DXS to realise increased revenue growth and improve patient outcomes by bringing our new Long-Term Condition management health care solutions to market – particularly as they will be supported by central funding. These solutions, in which we have invested over a number of years, all present significant efficiency savings to both GP Practices and the NHS.The Directors of DXS International plc accept responsibility for this announcement.Enquiries:

Note to Editors:About DXSDXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.